Cost-effectiveness analysis of gene-expression-based prognostic tests for patients with early-stage breast cancer in South Korea
Authors:
Open Access
- 26 November 2025
- journal article
- research article
- Published by Springer Nature in Cost Effectiveness and Resource Allocation
- Vol. 24 (1)
Abstract
Adjuvant chemotherapy (ACT) is a common treatment modality for patients with breast cancer; however, not all patients benefit from this therapy. To identifKeywords
Funding Information
- National Research Foundation of Korea (RS-2023-00270788)
- Gencurix Inc.
This publication has 51 references indexed in Scilit:
- Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15)The Breast, 2025
- Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancerBreast Cancer, 2023
- Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapyEuropean Journal of Cancer, 2023
- Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third VersionApplied Health Economics and Health Policy, 2022
- Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer–Specific Mortality Among US WomenJAMA Oncology, 2021
- Delayed initiation of adjuvant chemotherapy in older women with breast cancerCancer Medicine, 2020
- Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2–14)The Breast, 2020
- A method for using real world data in breast cancer modelingJournal of Biomedical Informatics, 2016
- Economic evaluation of the 21-gene signature (Oncotype DX®) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03)Breast Cancer Research and Treatment, 2010
- Optimal timing of adjuvant treatment in patients with early breast cancerMedical Oncology, 2010